|
USRE28819E
(en)
|
1972-12-08 |
1976-05-18 |
Syntex (U.S.A.) Inc. |
Dialkylated glycol compositions and medicament preparations containing same
|
|
US4255329A
(en)
|
1973-10-02 |
1981-03-10 |
Syva Company |
Double receptor fluorescent immunoassay
|
|
US4117149A
(en)
|
1975-09-12 |
1978-09-26 |
Pfizer Inc. |
4-oxo-4h-benzopyrans as animal growth promotants
|
|
US4261928A
(en)
|
1977-08-05 |
1981-04-14 |
Sterling Drug Inc. |
2-Benzoyl-8-(2-chloro-4-methoxyphenoxy)-1-phenyl-1-octanone
|
|
US4171365A
(en)
|
1977-08-05 |
1979-10-16 |
Sterling Drug Inc. |
Antiviral aryloxyalkylpyrazoles
|
|
US4232161A
(en)
|
1979-10-24 |
1980-11-04 |
Sterling Drug Inc. |
4-[6-(2-Chloro-4-methoxyphenoxy)hexyl]-3,5-diethyl-1-(2-pyridinyl)-1H-pyrazole
|
|
US4234725A
(en)
|
1979-10-24 |
1980-11-18 |
Sterling Drug Inc. |
4-[6-(2-Chloro-4-methoxyphenoxy)hexyl]-3,5-diethyl-1-[4-(4-morpholinyl)-1-oxobutyl]-1H-pyrazole
|
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4358603A
(en)
|
1981-04-16 |
1982-11-09 |
Syntex (U.S.A.) Inc. |
Acetal stabilized prostaglandin compositions
|
|
US4668640A
(en)
|
1981-12-11 |
1987-05-26 |
Abbott Laboratories |
Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins
|
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
|
GB2120242A
(en)
|
1982-04-30 |
1983-11-30 |
Erba Farmitalia |
Ergoline derivatives
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4764521A
(en)
|
1983-07-18 |
1988-08-16 |
Eli Lilly And Company |
Leukotriene antagonists and a method of use there as
|
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
IT1246382B
(it)
|
1990-04-17 |
1994-11-18 |
Eurand Int |
Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
|
|
US5543390A
(en)
|
1990-11-01 |
1996-08-06 |
State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University |
Covalent microparticle-drug conjugates for biological targeting
|
|
US6010715A
(en)
|
1992-04-01 |
2000-01-04 |
Bertek, Inc. |
Transdermal patch incorporating a polymer film incorporated with an active agent
|
|
US6024975A
(en)
|
1992-04-08 |
2000-02-15 |
Americare International Diagnostics, Inc. |
Method of transdermally administering high molecular weight drugs with a polymer skin enhancer
|
|
US5315015A
(en)
|
1992-11-10 |
1994-05-24 |
Hoffmann-La Roche Inc. |
Compounds having improved fluorescence in fluorescence polarization immunoassays and immunoassays utilizing same
|
|
US6274552B1
(en)
|
1993-03-18 |
2001-08-14 |
Cytimmune Sciences, Inc. |
Composition and method for delivery of biologically-active factors
|
|
US5521202A
(en)
|
1993-04-07 |
1996-05-28 |
Taiho Pharmaceutical Co., Ltd. |
Thiazolidine derivatives and pharmaceutical compositions containing the same
|
|
US5523092A
(en)
|
1993-04-14 |
1996-06-04 |
Emory University |
Device for local drug delivery and methods for using the same
|
|
US5985307A
(en)
|
1993-04-14 |
1999-11-16 |
Emory University |
Device and method for non-occlusive localized drug delivery
|
|
US6004534A
(en)
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
|
US5744368A
(en)
|
1993-11-04 |
1998-04-28 |
Research Foundation Of State University Of New York |
Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR)
|
|
US5759542A
(en)
|
1994-08-05 |
1998-06-02 |
New England Deaconess Hospital Corporation |
Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
|
|
US5660854A
(en)
|
1994-11-28 |
1997-08-26 |
Haynes; Duncan H |
Drug releasing surgical implant or dressing material
|
|
US5983134A
(en)
|
1995-04-23 |
1999-11-09 |
Electromagnetic Bracing Systems Inc. |
Electrophoretic cuff apparatus drug delivery system
|
|
US6316652B1
(en)
|
1995-06-06 |
2001-11-13 |
Kosta Steliou |
Drug mitochondrial targeting agents
|
|
US6167301A
(en)
|
1995-08-29 |
2000-12-26 |
Flower; Ronald J. |
Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
|
|
US6039975A
(en)
|
1995-10-17 |
2000-03-21 |
Hoffman-La Roche Inc. |
Colon targeted delivery system
|
|
TW345603B
(en)
|
1996-05-29 |
1998-11-21 |
Gmundner Fertigteile Gmbh |
A noise control device for tracks
|
|
US5985317A
(en)
|
1996-09-06 |
1999-11-16 |
Theratech, Inc. |
Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
|
|
US6139865A
(en)
|
1996-10-01 |
2000-10-31 |
Eurand America, Inc. |
Taste-masked microcapsule compositions and methods of manufacture
|
|
US6131570A
(en)
|
1998-06-30 |
2000-10-17 |
Aradigm Corporation |
Temperature controlling device for aerosol drug delivery
|
|
US5860957A
(en)
|
1997-02-07 |
1999-01-19 |
Sarcos, Inc. |
Multipathway electronically-controlled drug delivery system
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US5948433A
(en)
|
1997-08-21 |
1999-09-07 |
Bertek, Inc. |
Transdermal patch
|
|
JP4395200B2
(ja)
|
1997-10-28 |
2010-01-06 |
バンドー化学株式会社 |
皮膚貼付薬シート及びそのための基材シートの製造方法
|
|
US6048736A
(en)
|
1998-04-29 |
2000-04-11 |
Kosak; Kenneth M. |
Cyclodextrin polymers for carrying and releasing drugs
|
|
UA73092C2
(uk)
|
1998-07-17 |
2005-06-15 |
Брістол-Майерс Сквібб Компані |
Таблетка з ентеросолюбільним покриттям і спосіб її приготування
|
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
|
US6256533B1
(en)
|
1999-06-09 |
2001-07-03 |
The Procter & Gamble Company |
Apparatus and method for using an intracutaneous microneedle array
|
|
CA2396079A1
(en)
|
2000-01-07 |
2001-07-19 |
Transform Pharmaceuticals, Inc. |
High-throughput formation, identification, and analysis of diverse solid-forms
|
|
US6261595B1
(en)
|
2000-02-29 |
2001-07-17 |
Zars, Inc. |
Transdermal drug patch with attached pocket for controlled heating device
|
|
US7071218B2
(en)
|
2001-11-15 |
2006-07-04 |
Incyte San Diego Incorporated |
N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases
|
|
CA2486869C
(en)
|
2002-05-31 |
2011-09-13 |
Proteotech, Inc. |
Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
|
|
TW200403061A
(en)
|
2002-06-04 |
2004-03-01 |
Glaxo Group Ltd |
Pharmaceutical compositions
|
|
WO2004096808A1
(en)
|
2003-04-28 |
2004-11-11 |
De Novo Pharmaceuticals Limited |
Triazine compounds and their use
|
|
US20050113394A1
(en)
|
2003-11-26 |
2005-05-26 |
Wood Allen W. |
Pharmaceutical compositions
|
|
EP1750862B1
(en)
|
2004-06-04 |
2011-01-05 |
Teva Pharmaceutical Industries Ltd. |
Pharmaceutical composition containing irbesartan
|
|
WO2006009826A1
(en)
|
2004-06-18 |
2006-01-26 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
|
JP2007284350A
(ja)
|
2004-07-27 |
2007-11-01 |
Takeda Chem Ind Ltd |
糖尿病治療剤
|
|
WO2006088694A1
(en)
|
2005-02-14 |
2006-08-24 |
Wyeth |
SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS
|
|
US20070000505A1
(en)
|
2005-02-24 |
2007-01-04 |
Philip Morris Usa Inc. |
Smoking article with tobacco beads
|
|
US20070043096A1
(en)
|
2005-07-18 |
2007-02-22 |
Horizon Therapeutics, Inc. |
Unit dose form with ibuprofen-famotidine admixture
|
|
RU2431473C2
(ru)
|
2005-09-23 |
2011-10-20 |
Ф. Хоффманн-Ля Рош Аг |
Новая лекарственная форма
|
|
EP2108644B1
(en)
|
2006-11-24 |
2016-07-20 |
AC Immune S.A. |
N-(Methyl)-pyridin-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins
|
|
BRPI0718874A2
(pt)
|
2006-12-22 |
2015-06-23 |
Novartis Ag |
Compostos orgânicos
|
|
US8202873B2
(en)
|
2007-05-11 |
2012-06-19 |
Eli Lilly And Company |
2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists
|
|
TWI443090B
(zh)
|
2007-05-25 |
2014-07-01 |
Abbvie Deutschland |
作為代謝性麩胺酸受體２（ｍｇｌｕ２ 受體）之正向調節劑之雜環化合物
|
|
ES2351274T3
(es)
|
2007-06-06 |
2011-02-02 |
Torrent Pharmaceuticals Ltd |
Nuevos compuestos.
|
|
JP5451602B2
(ja)
|
2007-06-08 |
2014-03-26 |
アッヴィ・インコーポレイテッド |
キナーゼ阻害薬としての５−ヘテロアリール置換インダゾール類
|
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
EP2628726A1
(en)
|
2008-03-26 |
2013-08-21 |
Novartis AG |
Hydroxamate-based inhibitors of deacetylases b
|
|
JO3041B1
(ar)
|
2008-07-25 |
2016-09-05 |
Galapagos Nv |
مركبات جديدة مفيدة لمعالجة الأمراض التنكسية والالتهابية
|
|
US7994171B2
(en)
|
2008-09-11 |
2011-08-09 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US8048887B2
(en)
|
2008-09-11 |
2011-11-01 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
CA3222620A1
(en)
|
2008-10-20 |
2010-04-29 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of transthyretin
|
|
US9034911B2
(en)
|
2008-10-28 |
2015-05-19 |
Arena Pharmaceuticals, Inc. |
Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto
|
|
US8697685B2
(en)
|
2008-11-20 |
2014-04-15 |
Glaxosmithkline Llc |
Chemical compounds
|
|
BR112012008849A2
(pt)
|
2009-10-14 |
2015-09-22 |
Schering Corp |
composto, composição farmacêutica, e, uso de um composto
|
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
|
US20110144211A1
(en)
|
2009-12-11 |
2011-06-16 |
Lars Hermann |
Use of microcrystalline cellulose for interfering with the extraction of ephedrine
|
|
CN106943403A
(zh)
*
|
2010-04-07 |
2017-07-14 |
弗特克斯药品有限公司 |
药物组合物和其给药方法
|
|
WO2011140333A1
(en)
|
2010-05-07 |
2011-11-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Identification of stabilizers of multimeric proteins
|
|
JP6158092B2
(ja)
|
2010-12-16 |
2017-07-05 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
ケモカイン受容体調節因子としての硫黄誘導体
|
|
PL2729128T3
(pl)
|
2011-07-07 |
2017-05-31 |
Janssen Sciences Ireland Uc |
Preparat darunawiru
|
|
CN105142615A
(zh)
|
2011-09-14 |
2015-12-09 |
细胞基因公司 |
环丙烷羧酸{2-[(1s)-1-(3-乙氧基-4-甲氧基-苯基)-2-甲烷磺酰基-乙基]-3-氧代-2,3-二氢-1h-异吲哚-4-基}-酰胺的制剂细胞基因公司公司设立的州：特拉华州
|
|
US9169214B2
(en)
*
|
2012-12-21 |
2015-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
|
|
US10501418B2
(en)
|
2014-02-14 |
2019-12-10 |
Exelixis, Inc. |
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
|
|
US20160045609A1
(en)
|
2014-08-14 |
2016-02-18 |
Mamoun M. Alhamadsheh |
Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life
|
|
CR20170540A
(es)
|
2015-06-04 |
2018-02-02 |
Pfizer |
Formas de dosificación solidas de palbociclib
|
|
PT4070788T
(pt)
|
2015-06-30 |
2023-06-06 |
Gilead Sciences Inc |
Formulações farmacêuticas
|
|
AU2016304408B2
(en)
|
2015-07-31 |
2019-02-21 |
Pfizer Inc., |
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors
|
|
TW202332423A
(zh)
*
|
2016-10-12 |
2023-08-16 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
|
CN116730921A
(zh)
|
2017-02-17 |
2023-09-12 |
文涵治疗有限公司 |
Ag-10的制备方法、其中间体及其盐
|
|
EP3675827A1
(en)
|
2017-08-30 |
2020-07-08 |
Acadia Pharmaceuticals Inc. |
Formulations of pimavanserin
|
|
SG11202009073WA
(en)
|
2018-03-23 |
2020-10-29 |
Eidos Therapeutics Inc |
Methods of treating ttr amyloidosis using ag10
|
|
EP3836920B1
(en)
|
2018-08-17 |
2025-10-01 |
Eidos Therapeutics, Inc. |
Formulations of ag10
|
|
US12144812B2
(en)
|
2020-05-06 |
2024-11-19 |
Corcept Therapeutics Incorporated |
Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators
|
|
EP4243783A1
(en)
|
2020-11-11 |
2023-09-20 |
Spero Therapeutics, Inc. |
High dosage tebipenem pivoxil tablet formulation
|
|
US20230330006A1
(en)
|
2020-12-18 |
2023-10-19 |
Amneal Complex Products Rearch LLC |
Sustained Release Compositions Comprising Liothyronine
|
|
WO2024182635A1
(en)
|
2023-03-01 |
2024-09-06 |
Eidos Therapeutics, Inc. |
Potent transthyretin (ttr) stabilization in ttr amyloidosis patients receiving acoramidis
|